603TiP Phase II, open-label study of erdafitinib in adult...

Annals of Oncology 2020 / 09 Vol. 31

603TiP Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations

Schuler, M., Tabernero, J., Massard, C., Iyer, G. Vasudeva, Witt, O., Doi, T., Qin, S., Lu-Emerson, C., Hargrave, D., Garcia-Corbacho, J., Little, S., Xia, Q., Santiago-Walker, A., Moy, C.H., Hammond,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.717
Date:
September, 2020
File:
PDF, 119 KB
2020
Conversion to is in progress
Conversion to is failed